Celso A Reis Selected Research

Proteins (Proteins, Gene)

1/2023	Differential Protein and Glycan Packaging into Extracellular Vesicles in Response to 3D Gastric Cancer Cellular Organization.
8/2021	Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells.
1/2021	Aberrant protein glycosylation in cancer: implications in targeted therapy.
1/2021	Heparan Sulfate Biosynthesis and Sulfation Profiles as Modulators of Cancer Signalling and Progression.
1/2019	Different isolation approaches lead to diverse glycosylated extracellular vesicle populations.
1/2018	Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.
9/2016	Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.
8/2016	Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
8/2013	Challenging the limits of detection of sialylated Thomsen-Friedenreich antigens by in-gel deglycosylation and nano-LC-MALDI-TOF-MS.
12/2012	Epithelial E- and P-cadherins: role and clinical significance in cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Celso A Reis Research Topics

Disease

90	Neoplasms (Cancer) 03/2024 - 06/2003
31	Stomach Neoplasms (Stomach Cancer) 10/2023 - 09/2003
29	Carcinoma (Carcinomatosis) 12/2020 - 03/2002
16	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2007
15	Infections 01/2022 - 01/2004
8	Metaplasia 01/2011 - 03/2002
7	Breast Neoplasms (Breast Cancer) 08/2015 - 09/2003
6	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 08/2011
6	Carcinogenesis 11/2016 - 08/2009
5	Inflammation (Inflammations) 03/2024 - 09/2015
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 06/2013
4	Hypoxia (Hypoxemia) 01/2018 - 01/2015
3	Polyps 12/2020 - 06/2009
3	Adenocarcinoma 06/2018 - 01/2011
3	Persistent Infection 11/2016 - 09/2015
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 08/2015 - 03/2002
3	Gastritis 03/2013 - 12/2005
2	Stomach Diseases 05/2023 - 08/2016
2	Duodenal Ulcer (Curling's Ulcer) 05/2023 - 08/2013
2	Microsatellite Instability 01/2021 - 09/2018
2	Tuberculosis (Tuberculoses) 01/2021 - 01/2020
2	Pathologic Processes 10/2018 - 11/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 06/2018 - 01/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 01/2016
1	Fibrosis (Cirrhosis) 03/2024

Drug/Important Bio-Agent (IBA)

54	Polysaccharides (Glycans)IBA 10/2023 - 02/2006
29	AntigensIBA 10/2023 - 06/2003
20	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2010
17	Glycoproteins (Glycoprotein)IBA 02/2022 - 09/2003
17	MucinsIBA 06/2018 - 03/2002
16	Sialyl Lewis X AntigenIBA 01/2023 - 11/2004
14	EnzymesIBA 03/2024 - 10/2006
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2005
12	Cadherins (E-Cadherin)IBA 10/2016 - 07/2007
10	CarbohydratesIBA 06/2013 - 03/2002
9	GlycosyltransferasesIBA 11/2022 - 06/2003
9	Monoclonal AntibodiesIBA 02/2022 - 03/2002
9	EpitopesIBA 01/2021 - 06/2003
6	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 08/2011
6	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2021 - 11/2004
6	SialyltransferasesIBA 01/2020 - 01/2013
4	AntibodiesIBA 05/2023 - 10/2003
4	Proteoglycans (Proteoglycan)IBA 01/2023 - 01/2016
4	Carrier Proteins (Binding Protein)IBA 02/2022 - 01/2019
4	GlycoconjugatesIBA 01/2022 - 01/2013
4	Hyaluronic Acid (Hyaluronan)IBA 02/2021 - 10/2018
4	Peptides (Polypeptides)IBA 01/2021 - 06/2003
4	sialosyl-Tn antigenIBA 01/2011 - 10/2004
3	LigandsIBA 03/2024 - 11/2004
3	Heparitin Sulfate (Heparan Sulfate)IBA 11/2022 - 01/2021
3	VaccinesIBA 02/2022 - 10/2003
3	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 01/2022 - 02/2006
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 06/2016
3	Protein Isoforms (Isoforms)IBA 01/2020 - 04/2013
3	Mucin-1 (CA 15-3 Antigen)IBA 10/2018 - 02/2006
3	LectinsIBA 01/2018 - 01/2012
3	Lewis Blood Group AntigensIBA 01/2017 - 10/2006
3	IntegrinsIBA 08/2016 - 11/2013
2	BiglycanIBA 03/2024 - 03/2021
2	Phosphotransferases (Kinase)IBA 10/2023 - 01/2020
2	RON proteinIBA 10/2023 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 10/2023 - 01/2020
2	Syndecan-4IBA 01/2023 - 08/2009
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 11/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2013
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 08/2021 - 10/2017
2	Thomsen-Friedenreich antigenIBA 01/2021 - 09/2018
2	Blood Group Antigens (Blood Groups)IBA 01/2021 - 01/2010
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2007
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2021 - 04/2013
2	GlycosaminoglycansIBA 01/2021 - 01/2021
2	Neuraminidase (Sialidase)IBA 01/2021 - 01/2015
2	TransferasesIBA 01/2020 - 06/2003
2	ChitosanIBA 01/2020 - 12/2013
2	beta-Galactoside alpha-2,3-SialyltransferaseIBA 01/2019 - 01/2014
2	Phenobarbital (Luminal)FDA Link 12/2017 - 09/2014
2	Galectin 3 (LGALS3)IBA 12/2016 - 01/2015
2	AcetylglucosamineIBA 02/2016 - 05/2006
2	GlycopeptidesIBA 08/2011 - 02/2006
2	Gastric MucinsIBA 03/2006 - 03/2002
2	Cancer VaccinesIBA 02/2006 - 02/2006
2	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 05/2005 - 10/2003
2	SaponinsIBA 05/2005 - 10/2003
1	DecorinIBA 03/2024
1	Heparin (Liquaemin)FDA LinkGeneric 03/2024
1	gag Gene Products (gag Protein)IBA 03/2024
1	SyndecansIBA 03/2024
1	durvalumabIBA 12/2023
1	GSK 1363089IBA 10/2023
1	B72.3 antibodyIBA 10/2023
1	Tyrosine (L-Tyrosine)FDA Link 10/2023
1	Proto-Oncogene Proteins c-metIBA 10/2023
1	Blocking AntibodiesIBA 05/2023
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 11/2022

Therapy/Procedure

22	Therapeutics 12/2023 - 01/2012
6	Precision Medicine 01/2020 - 01/2016
4	Ligation 08/2016 - 02/2010
2	Immunotherapy 12/2023 - 02/2006
2	Microspheres (Microsphere) 01/2020 - 12/2013